Estee Lauder Cos (NYSE:EL) 주식

ESTEE LAUDER COMPANIES-CL A

Estee Lauder Cos

Estée Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Bear,Walks,On,Chinese,Yuan,Renminbi,Bill,Banknotes,Background.,China

News

Options

Global

Markets

Movers

Tech

BABA

BIDU

NVDA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

마이클 버리는 2008년 미국 주택 시장에 대한 높은 수익을 올린 베팅으로 유명하며, 최근 중국 기술주에 대해 약세로 전환했다. 버리의 전환은 이전에 중국 기술 기업들에 대해 강세를 보였고, 최근 2024년 말까지 알리바바 그룹 홀딩(NYSE:BABA)와 JD닷컴(NASDAQ:JD)과 같은 기업들에 상당한 롱 포지션을 보유하고 있었기 때문에 주목할 만하다.

&#39;빅 쇼트&#39; 투자자 마이클 버리, 중국에 대해 약세 전환: 그가 지금 공개한 매도 목록은?

Kuala,Lumpur,,Malaysia,-,November,08,,2023:,Makeup,Products,On

Equities

OSCR

목요일(15일) 미국 증권거래위원회(SEC)에 제출한 13F 서류에 따르면, 2008년 주택 시장 붕괴를 정확히 예측한 &#39;빅 쇼트&#39;의 유명 투자자 마이클 버리는 1분기 동안 대부분의 주식에 대해 약세 전망으로 돌아선 가운데 화장품 대기업 에스티 로더 컴퍼니즈(NYSE:EL)의 지분을 두 배로 늘렸다.

&#39;빅 쇼트&#39; 마이클 버리: 1분기에 에스티로더 지분 2배 증가, 엔비디아 하락에 베팅, 중국 주식은 완전 처분

paypal-shutter2

Large Cap

Trading Ideas

AVTR

ILMN

MRNA

NBIX

PYPL

SWKS

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 스카이웍스 솔루션(NASDAQ:SWKS)의 주식은 회사가 1분기 실적을 발표하고 2분기 가이던스를 예상치 이하로 제시한 후 25.99% 하락했다. 애널리스트들은 주가 전망을 수정했다.

에스티 로더, 모더나 및 페이팔 등 지난주 하락한 10개의 대형주 (2월 3일-7일)

Estee Lauder Companies, Inc. (The) Common Stock

The Estee Lauder Companies Inc

ELYSIA

Envela Corp

Elastos - United States Dollar

PMGC Holdings Inc

ELATE HLDGS LTD PCL by ELATE HLDGS LTD PUBLIC COMPANY LIMITED

Elate Holdings Ltd

EL AL ISRAEL AIRLS LTD by EL AL Israel Airlines Ltd.

El AL Israel Airlines Ltd

ELAMEX S.A. DE C.V. by Elamex S.A. de C.V.

Elamex SA de CV

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health Inc

ELBIT MEDICAL TECHS by Elbit Medical Technologies Ltd

Elbit Medical Technologies Ltd

Electra Battery Materials Corporation - Common Stock

Electra Battery Materials Corp

Entergy Louisiana, Inc. Collateral Trust Mortgage Bonds, 4.875 % Series due September 1, 2066

ELECO HOLDINGS PLC by ELECO HOLDINGS PLC

ELECTRA STONE LTD ORD by Electra Stone Ltd

Electra Stone Ltd

Elecom Co Ltd

ELCOM INTL INC by Elcom International, Inc.

Elcom International Inc

EDP-Energias De Portugal SA

ELECTRIC CAR CO INC by Electric Car Company, Inc.

Electric Car Co Inc

Strategy Shares Eventide High Dividend ETF

WisdomTree Emerging Markets Local Debt Fund

ELECTRUM DISCOVERY CORP by ELECTRUM DISCOVERY CORP.

Electrum Discovery Corp

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals Inc

El.En. SpA

ELECTRIC ROYALTIES LTD by Electric Royalties Ltd.

Electric Royalties Ltd

ELEMENT FLEET MGMT CORP by Element Fleet Mgmt Corp.

Element Fleet Management Corp

Elektros Inc

ELEMENTAL ALTUS ROYALTIES by ELEMENTAL ALTUS ROYALTIES CORP.

Elemental Altus Royalties Corp

Elevation Oncology Inc

Endesa SA

e.l.f. Beauty Inc

aelf

E-L Financial Corp Ltd

ALPS Electrification Infrastructure ETF

ELEMENT GLOBAL INC by Element Global, Inc.

Element Global Inc

ELECTRIC & GAS TECH INC by Electric & Gas Technology, Inc.

ELIA SYSTEM OPERATOR SA by Elia System Operator SA/NV

Elia Group SA/NV

Direxion Daily LLY Bull 2X Shares

Elio Motors Inc

ELECTRIQ POWER HLDGS A by Electriq Power Holdings Inc.

Electriq Power Holdings Inc

Electriq Power Holdings Inc Warrants (25/01/2028)

Direxion Daily LLY Bear 1X Shares

Elixxer Ltd

Elkem ASA

GOLD ROAD RES LTD ORD by Gold Road Resources Ltd.

Gold Road Resources Ltd

Elah Holdings Inc

Ellaktor SA

Ellomay Capital Ltd Ordinary Shares (Israel)

Ellomay Capital Ltd

ELRINGKLINGER AG UNSP/ADR by Elringklinger Ag

ElringKlinger AG

Elixinol Wellness Ltd Ordinary Shares

ELIXINOL WELLNESS LTD by Elixinol Wellness Ltd.

Elixinol Wellness Ltd

Series Portfolios Trust Elm Market Navigator ETF

Elmer Bancorp Inc

Electromed Inc

Elme Communities

Element79 Gold Corp

ELEMENT79 GOLD CORP by Element79 Gold Corp.

Elemon

ELECTRIC LAST MILE SOLN A by Electric Last Mile Solutions Inc.

Electric Last Mile Solutions Inc

Element 25 Ltd

Elementis PLC

Elisa Oyj

Electric Last Mile Solutions Inc Warrants (24/06/2026)

ELANIX BIOTECHNOLOGIES AG by ELANIX BIOTECHNOLOGIES AG

Elecnor SA

Element Nutritional Sciences Inc Ordinary Shares

Elinx Corp

EMERGENCE GLOBAL ENTRPSE by EMERGENCE GLOBAL ENTERPRISES INC.

Emergence Global Enterprises Inc

Tidal Trust III Battleshares TSLA vs F ETF

Dogelon Mars

Elior Group SA

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals Inc

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)

Cia Paranaense De Energia Copel

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing four (4) Common Shares)

Elopak ASA

EL PUERTO LIVERPOOL SHS 1 by El Puerto de Liverpool S.A. de C.V.

El Puerto de Liverpool SAB de CV

Elong Power Holding Limited - Class A Ordinary Shares

Elong Power Holding Ltd

iShares ESG Advanced Investment Grade Corporate Bond ETF

ELRAY RESOURCES INC by Elray Resources, Inc.

Elray Resources Inc

Yinfu Gold Corp

EASTERN PLATINUM LTD NEW by Eastern Platinum Ltd.

Eastern Platinum Ltd

ELRON VENTURES LTD by Elron Ventures Ltd.

Elron Ventures Ltd

ELORO RESOURCES LTD by Eloro Resources Ltd.

Eloro Resources Ltd

AKTIEBOLAGET ELECTROLUX B by AB Electrolux

Electrolux AB

Equity Lifestyle Properties, Inc. Common Stock

Equity Lifestyle Properties Inc

Electro-Sensors Inc

Elis SA

ELECTRONIC SYS TECHNOLOGY by Electronic Systems Technology, Inc.

Electronic Systems Technology Inc

Eltek Ltd

Elementos Ltd

ELITE PHARMS INC by Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Inc

ELMOS SEMICONDUCTOR AG by Elmos Semiconductor AG

Elmos Semiconductor SE

Elicio Therapeutics Inc

Elutia Inc

Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Estee Lauder Cos, revealing an average target of $66.64, a high estimate of $90.00, and a low estimate of $55.00. Highlighting a 10.9% decrease, the current average has fallen from the previous average price target of $74.79. 
<img src="https://www.benzinga.com/files/images/story/2025/1748541709_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Estee Lauder Cos. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$63.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$62.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$66.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$62.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Christopher Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$67.00</td>
<td>$77.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Estee Lauder Cos. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Estee Lauder Cos compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Estee Lauder Cos's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Estee Lauder Cos analyst ratings.</a>
<h2>Unveiling the Story Behind Estee Lauder Cos</h2>
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
<h3>Estee Lauder Cos: Delving into Financials</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Decline in Revenue: Over the 3M period, Estee Lauder Cos faced challenges, resulting in a decline of approximately -9.9% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Estee Lauder Cos's net margin is impressive, surpassing industry averages. With a net margin of 4.48%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Estee Lauder Cos's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.74% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.8%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.16, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About Estee Lauder Cos Stock

Barclays analyst Lauren Lieberman maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Equal-Weight and raises the price target from $56 to $63.

Price Target

Barclays Maintains Equal-Weight on Estee Lauder Cos, Raises Price Target to $63

Activist investor&nbsp;Dan&nbsp;Loeb‘s&nbsp;Third Point LLC&nbsp;acquired a significant stake in consumer health company&nbsp;Kenvue Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>)&nbsp;<a target="_blank" href="https://www.benzinga.com/topic/dan-loeb" rel="noreferrer noopener">in the first quarter of 2025</a>.
Kenvue was formerly a part of&nbsp;Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) before becoming an independent&nbsp;<a href="https://www.benzinga.com/news/large-cap/24/08/40659011/johnson-johnson-spin-off-kenvue-wins-lawsuit-over-pain-killer-tylenol-rapid-release-gelcaps" target="_blank" rel="noreferrer noopener">company in August 2023</a>.
The company&#8217;s major products include several J&amp;J brands, including Tylenol, <a href="https://www.benzinga.com/news/large-cap/23/05/32205951/kenvues-ipo-extravaganza-a-historic-41-billion-spinoff-from-johnson-johnson">Listerine, Neutrogena, and Nicorette</a>.&nbsp;
According to recent 13F filings, reflecting his holding as of March 31, 2025, Loeb bought an 8.9 million stake in the company, thereby placing it <a target="_blank" href="https://www.benzinga.com/news/large-cap/25/05/45472025/loebs-third-point-exits-meta-tesla-rotates-into-staples-telecom-industrials" rel="noreferrer noopener">among his top five holdings</a>.
Let's have a look at the company&#8217;s major events.
<ul class="wp-block-list">
<li>On May 8, the company reported first-quarter 2025 sales of $3.74 billion, beating <a href="https://www.benzinga.com/general/health-care/25/05/45297027/neutrogena-maker-kenvue-beats-profit-forecast-ups-sales-outlook" target="_blank" rel="noreferrer noopener">the&nbsp;consensus of $3.68 billion</a>.</li>
<li>Kenvue updated its fiscal 2025 outlook to reflect current foreign exchange rates and the estimated impact of <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">higher costs due to tariffs</a>.&nbsp;</li>
<li>The company now expects a net sales increase of +1% to +3% (-1% to +1% prior) year-over-year, with organic sales growth of +2% to +4 (unchanged) and a ~1% headwind from foreign currency translation <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">(earlier expected around 3%)</a>.</li>
<li>Also, Kenvue appointed Amit Banati as the company's CFO, effective May 12. Banati will <a href="https://www.benzinga.com/pressreleases/25/05/b45280347/kenvue-announces-chief-financial-officer-transition" target="_blank" rel="noreferrer noopener">succeed Paul Ruh</a>.</li>
<li>On April 16, Kenvue announced a five-year collaboration with Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) to establish a strong foundation for transforming digital operations through advanced&nbsp;<a href="https://www.benzinga.com/pressreleases/25/04/b44834009/kenvue-announces-5-year-collaboration-with-microsoft-to-transform-digital-operations" target="_blank" rel="noreferrer noopener">Artificial Intelligence (AI) technologies</a>.</li>
<li>Kenvue shares rose nearly 11.5% year to date, compared to the&nbsp;Renaissance IPO ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPO#NYSE">IPO</a>), which fell about 1.36%&nbsp;over the same time frame.</li>
<li>The company&#8217;s shares also fared well compared to its closest peer, Estee Lauder Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>), which declined 15.06% year to date.</li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45528489/loebs-third-point-boosts-apollo-stake-275-soho-house-121-in-q1-bet" target="_blank" rel="noreferrer noopener">Loeb&#8217;s Third Point Boosts Apollo Stake 275%, Soho House 121% In Q1 Bet</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

KVUE

MSFT

Why Dan Loeb Just Made Kenvue One Of His Top Holdings

JPMorgan analyst Christopher Horvers reiterated the Overweight rating on Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>), <a href="https://www.benzinga.com/quote/ULTA/analyst-ratings" target="_blank" rel="noreferrer noopener">raising the price forecast from $475 to $477.</a>
Ulta will report first-quarter earnings on reports Thursday, May 29, after the market close.
Horvers notes that during Ulta&#8217;s fourth-quarter earnings update, the company mentioned comparable sales trends were nearly flat. They&#8217;re starting to improve thanks to the momentum of its semi-annual event and a more stable consumer and beauty market.
Also Read: <a href="https://www.benzinga.com/news/large-cap/25/05/45499101/big-short-legend-michael-burry-bets-big-on-lipstick-index-is-he-bracing-for-a-recession" target="_blank" rel="noreferrer noopener">&#8216;Big Short&#8217; Legend Michael Burry Bets Big On Lipstick Index: Is He Bracing For A Recession?</a>
Broadly, the analyst sees beauty category growth normalizing to its historical 3%-4% range, positioning Ulta to gain share thanks to its unique mix of mass and prestige offerings and strong industry position. This, Horvers writes, should lead to better margin conversion, earnings growth, and potential multiple expansion.
The analyst also points out that, during the firm&#8217;s April 3 RRU conference, Ulta Beauty CEO Kecia Steelman maintained a positive outlook. She highlighted consistent consumer behavior since the Q4 report and strong performance during promotional periods, even as overall engagement remained soft in quieter times.
Horvers observes that since Ulta's last report, quarter-to-date trends have shown modest improvement—about 50 basis points—according to Nielsen and Circana data, with momentum building sequentially from January through March.
Additional insights from Coty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) and Estee Lauder Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) suggest that April performed better than March. Based on this, the analyst has raised its forecast to 0.7%.
Although Ulta did not offer formal second-quarter guidance, Horvers notes that management expects comparable sales to remain roughly in line, with the second and third quarters benefiting from easier year-over-year comparisons.
While consumer behavior appears stable or slightly better than a year ago, fading market share pressures and stronger execution should support improvement.
Price Action: Ulta Beauty shares are trading lower by 1.38% to $405.04 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45553623/retail-etfs-rattle-as-tariffs-yields-consumer-caution-pressure-big-box-stocks" target="_blank" rel="noreferrer noopener">Retail ETFs Rattle As Tariffs, Yields, Consumer Caution Pressure Big-Box Stocks</a></li>
</ul>
Image: Shutterstock

General

COTY

ULTA

Ulta Gets A Touch-Up: JPMorgan Lifts Price Target Ahead Of Q1 Earnings

A sharp jump in Treasury yields following Wednesday's weak 20-year bond auction triggered a swift market reaction, with several high-growth and tech names plunging between 1:05 p.m. and 2:05 p.m. ET—the exact window 30-year <a href="https://www.benzinga.com/news/treasuries">yields spiked above 5.08%.</a>
Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) led the decline, falling 6.9%, followed by Hims &amp; Hers Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>), which dropped 5%, data from <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a> platform shows. 
AI infrastructure firm CoreWeave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) slid 4.4%, while Bitcoin-linked Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) tumbled 4.3%. 
Trading platform Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) lost 3.7%.
The selloff came as investors repriced risk across equities amid fears of persistently higher rates, sparked by soft demand at the 20-year Treasury auction. 
The bid-to-cover ratio of 2.46 landed near the bottom quartile of the past 50 auctions, with the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>), sliding to a 19-month low.
Notable losers among the 20 movers with at least $10 billion market cap also included Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>), Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) and Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), with declines of 3.1%, 2.9% and 2.7%, respectively. 
Semiconductor names also came under pressure, as ON Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) fell 2.8%, while Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) lost 3% during the hour-long selloff. Other high-beta tech stocks such as Credo Technology Group Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) and Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) each dropped over 3%, reflecting broad-based risk aversion triggered by the Treasury market spike. 
The weakness extended into biotech and aerospace sectors as well, with Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) and Rocket Lab USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) down 2.7% and 3.5%, respectively.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Name</th>
<th>Price</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tempus AI</td>
<td>$60.39</td>
<td>-6.91%</td>
</tr>
<tr>
<td>Hims &amp; Hers Health</td>
<td>$58.27</td>
<td>-5.00%</td>
</tr>
<tr>
<td>CoreWeave</td>
<td>$104.33</td>
<td>-4.44%</td>
</tr>
<tr>
<td>Strategy</td>
<td>$399.58</td>
<td>-4.15%</td>
</tr>
<tr>
<td>Robinhood Markets</td>
<td>$64.11</td>
<td>-3.73%</td>
</tr>
<tr>
<td>Aurora Innovation</td>
<td>$6.17</td>
<td>-3.60%</td>
</tr>
<tr>
<td>Rocket Lab USA</td>
<td>$25.48</td>
<td>-3.51%</td>
</tr>
<tr>
<td>Credo Technology Group</td>
<td>$60.98</td>
<td>-3.24%</td>
</tr>
<tr>
<td>Mobileye Global</td>
<td>$15.88</td>
<td>-3.23%</td>
</tr>
<tr>
<td>Astera Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>)</td>
<td>$92.15</td>
<td>-3.21%</td>
</tr>
<tr>
<td>ServiceTitan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>)</td>
<td>$123.13</td>
<td>-3.07%</td>
</tr>
<tr>
<td>Palantir Technologies</td>
<td>$122.40</td>
<td>-3.05%</td>
</tr>
<tr>
<td>Super Micro Computer</td>
<td>$42.16</td>
<td>-3.04%</td>
</tr>
<tr>
<td>Estee Lauder Cos Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>)</td>
<td>$64.11</td>
<td>-2.96%</td>
</tr>
<tr>
<td>Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)</td>
<td>$260.26</td>
<td>-2.92%</td>
</tr>
<tr>
<td>Toll Brothers Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>)</td>
<td>$103.95</td>
<td>-2.89%</td>
</tr>
<tr>
<td>ON Semiconductor</td>
<td>$44.03</td>
<td>-2.82%</td>
</tr>
<tr>
<td>Summit Therapeutics</td>
<td>$25.59</td>
<td>-2.69%</td>
</tr>
<tr>
<td>Nvidia Corp. </td>
<td>$133.27</td>
<td>-2.69%</td>
</tr>
<tr>
<td>Kinsale Capital Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>)</td>
<td>$460.03</td>
<td>-2.64%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Benzinga Pro</figcaption></figure>
<h3 class="wp-block-heading">Wall Street Extend Lows</h3>
The S&amp;P 500 Index, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), deepened losses, falling 1.3% by 2:17 p.m. ET, while small caps were hit harder, with the Russell 2000 plunging 2.4%. 
All S&amp;P 500 sectors traded in negative territory, led by real estate, which dropped 2.7% under pressure from rising yields.
Gold miners, tracked by the VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>), were the only industry group holding gains, supported by a rise in bullion prices as investors sought safety amid Treasury volatility. 
The clean energy industry was the day's worst performer, with the Invesco WilderHill Clean Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBW#NYSE">PBW</a>) sliding 3.4%.
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45548192/tesla-enters-its-most-bullish-window-this-seasonal-trade-delivered-24-average-gain-over-10-years">Tesla Enters Its Most Bullish Window: This Seasonal Trade Delivered 24% Average Gain Over 10 Years </a></li>
</ul>
Photo: Shutterstock

Comments

Estee Lauder Cos

뉴스

파트너 / 기고자

벤징가 글로벌